$185 Billion Bain Capital in Talks to Buy Majority Stake in United States Drugmaker & Packaging Solutions PCI Pharma Services at $10 Billion Valuation, Key Shareholders are Mubadala Investment Company, KKR & Partners Group, PCI Pharma Services Acquired by Partners Group from Healthcare Investment Manager Frazier Healthcare Partners in 2016, Mubadala Investment Company & KKR Became Majority Shareholders in 2020
11th May 2025 | Hong Kong
Bain Capital ($185 billion AUM) has been reported to be in talks to buy a majority stake in United States drugmaker & packaging solutions PCI Pharma Services at $10 billion valuation. PCI Pharma Services key shareholders are Mubadala Investment Company, KKR & Partners Group. PCI Pharma Services was acquired by Partners Group from healthcare investment manager Frazier Healthcare Partners in 2016. In 2020, Mubadala Investment Company & KKR became majority shareholders. PCI Pharma Services – PCI is your world leading CDMO, providing integrated end-to-end drug development, manufacturing, and packaging solutions to increase product speed to market and opportunities for commercial success. PCI brings the proven experience that comes with more than 90 successful product launches each year and over five decades in the delivery of CDMO services. With 30 sites across Australia, Canada, North America, the UK, and Europe and over 6000+ dedicated employees, together, delivering life changing therapies. Leading technology and continued investment enable us to deliver development to commercialization solutions throughout the product lifecycle, collaborating with our clients to improve the lives of patients globally.
“ $185 Billion Bain Capital in Talks to Buy Majority Stake in United States Drugmaker & Packaging Solutions PCI Pharma Services at $10 Billion Valuation, Key Shareholders are Mubadala Investment Company, KKR & Partners Group, PCI Pharma Services Acquired by Partners Group from Healthcare Investment Manager Frazier Healthcare Partners in 2016, Mubadala Investment Company & KKR Became Majority Shareholders in 2020 “
$185 Billion Bain Capital in Talks to Buy Majority Stake in United States Drugmaker & Packaging Solutions PCI Pharma Services at $10 Billion Valuation, Key Shareholders are Mubadala Investment Company, KKR & Partners Group, PCI Pharma Services Acquired by Partners Group from Healthcare Investment Manager Frazier Healthcare Partners in 2016, Mubadala Investment Company & KKR Became Majority Shareholders in 2020

Sign Up / Register
Caproasia Users
- Manage $20 million to $3 billion of assets
- Invest $3 million to $300 million
- Advise institutions, billionaires, UHNWs & HNWs
Caproasia Platforms | 11,000 Investors & Advisors
- Caproasia.com
- Caproasia Access
- Caproasia Events
- The Financial Centre | Find Services
- Membership
- Family Office Circle
- Professional Investor Circle
- Investor Relations Network
Monthly Roundtable & Networking
Family Office Programs
The 2025 Investment Day
- March - Hong Kong
- March - Singapore
- July - Hong Kong
- July - Singapore
- Sept- Hong Kong
- Sept - Singapore
- Oct- Hong Kong
- Nov - Singapore
- Visit: The Investment Day | Register: Click here
Caproasia Summits
- The Institutional Investor Summit
- The Investment / Alternatives Summit
- The Private Wealth Summit
- The Family Office Summit
- The CEO & Entrepreneur Summit
- The Capital Markets Summit
- The ESG / Sustainable Investment Summit